
Metfienz-PG2 Tablet SR
Marketer
Plena Remedies
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metfienz-PG2 Tablet SR
GlucoBalance SR is a dual-action formulation designed to manage blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates efficient insulin use, resulting in reduced blood sugar. GlucoBalance SR should be administered as prescribed by your physician, adhering to the recommended dosage and timeframe. Ingestion with food is advised to minimize gastrointestinal discomfort. Missed doses should be taken promptly; however, if nearing the next scheduled dose, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it may heighten the risk of adverse effects.
Uses of Metfienz-PG2 Tablet SR
Managing Type 2 diabetes
Major Benefits of Metfienz-PG2 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metfienz-PG2 Tablet SR should be administered with a meal.
Common Side effects of Metfienz-PG2 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metfienz-PG2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metfienz-PG2 Tablet SR should be administered with a meal.
How Metfienz-PG2 Tablet SR works:
Metfienz-PG2 SR tablets contain a triple-drug formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct actions to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metfienz-PG2 Tablet SR and alcohol poses a significant health risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Metfienz-PG2 tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Metfienz-PG2 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Metfienz-PG2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Metfienz-PG2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Metfienz-PG2 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metfienz-PG2 Tablet SR :
Should you forget to take a Metfienz-PG2 Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metfienz-PG2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
